Bush's war and the Egyptian elections

Posted on September 06, 2008 in Impotence young men

The fear of clowns is known as Caulrophobia. Quite simply, I think it's very valid because they're the product of a diseased mind. The sheer number of sites dedicated to clown-bashing is proof that I'm not mad (ok, maybe not proof, but certainly credence). I've even included four of my scariest clowns for your sheer terror. Also, check out I Hate Clowns and Scary or Not Cheap Generic Viagra

Tags: clown, proof, sheer, bashing, included

Ten-Year Predicted Coronary Heart Disease Risk in HIV-Infected Men and Women

Posted on September 06, 2008 in Generic biologicals

Clinical Infectious Diseases on the net September 12, 2007 \"Statistics. Bounded by HIV-infected adults, intervening extension to antiretroviral drug exposures, customer overweight additionally having a low income let know were correlated with increased predicted CHD risk. This comprises a be inadequate to target HIV-infected cavalry additionally women with these characteristics owing to vascular risk splinter screening.\" Cheap Generic Viagra

Tags: infected, risk, hiv, additionally, women

Urolithiasis [kidney stones] in HIV-Positive Patients Treated with Atazanavir

Posted on September 06, 2008 in Generic biologicals

Clinical Infectious Diseases on the net September 12, 2007 \"Patients with low water intake, huge urinary pH, furthermore a extinct motive of urinary stones may have a higher risk of atazanavir-associated urine crystallization.\" Cheap Generic Viagra

Tags: urinary, patients, atazanavir, stones, motive

Vitamin E- More of The Rest of the Story

Posted on September 06, 2008 in Medical care

Here are two historical perspectives on the value of Vitamin E to our health. VITAMIN E: A CURE IN SEARCH OF RECOGNITION, by Dr Andrew Saul is a major historical presentation of the trails, tribulations, and the Canadian connection to determining the effectiveness of vitamin E. In compelling detail, Dr Saul lays out why it does what it does. More importantly, he proves it. In Antioxidant Vitamins Prevent Heart Disease: Verification from the American Heart Association, Richard Passwater is equally evocactive. There is no doubt about Vitamin E efficacy. Cheap Generic Viagra

Tags: vitamin, heart, dr, saul, historical

Narcotic 'lollipop' is big seller

Posted on September 05, 2008 in Prescriptions

By JOHN CARREYROU / The Wall Street Journal While pregnant with her second child three years ago, Tiare Frontera suffered from bad migraines. A neurologist prescribed Actiq, a berry-flavored lozenge on a stick that looks and tastes like a lollipop. After a few sucks on the medicine, she says a rush of euphoria washed her headache away. Soon, Mrs. Frontera, who had struggled with addictions to milder narcotics, was consuming five Actiq lozenges a day. She spent the rest of her pregnancy on what she describes as the strongest high she has ever experienced. When she gave birth, her baby son was cranky and wouldn’t sleep. Doctors told her he had become addicted to the drug and was in withdrawal. Mrs. Frontera is one of thousands of Americans who are prescribed Actiq, an extremely potent narcotic, for ailments that have nothing to do with its intended use. The Food and Drug Administration approved the drug eight years ago for use only in cancer patients who suffer intense bouts of pain that other narcotics don’t relieve. In the first half of this year, oncologists, or cancer doctors, accounted for only 1 percent of the 187,076 Actiq prescriptions filled at retail pharmacies in the U.S., according to Verispan, whose surveys of prescription-drug sales are widely used in the industry. Data gathered from a network of doctors by research firm ImpactRx between June 2005 and October 2006 suggest that more than 80 percent of patients who use the drug don’t have cancer. Instead, doctors prescribe it “off label” for nonapproved uses such as headaches or back pain. Off-label prescribing isn’t illegal, but it can be dangerous — especially with a drug like Actiq, which has a high potential for abuse and may kill those who overdose on it. The FDA prohibits pharmaceutical companies from marketing their drugs for off-label uses. For Actiq and a few other powerful drugs, the agency requires strict programs to control distribution and usage. Actiq’s broad off-label use raises questions about whether those restrictions are sufficiently protecting patients. “We all know (Actiq) is being misused and abused,” says Brian Sweet, a manager in the pharmacy unit of health insurer WellPoint Inc. After witnessing a surge in Actiq prescriptions, WellPoint cracked down by making doctors show that patients being prescribed the drug have cancer. Actiq’s maker, Cephalon Inc., says it doesn’t market the drug for unapproved uses. While acknowledging that Actiq is widely used off-label, it says it can’t control how doctors prescribe the drug. Yet the company walks a fine line by sending its sales representatives to pitch the drug to a broad range of doctors, ranging from sports-medicine specialists to family practitioners. It gives these doctors coupons for free samples. Cephalon says the visits are appropriate because cancer patients often get treated for their pain by physicians who don’t specialize in cancer. Actiq contains fentanyl, a highly addictive substance about 80 times as potent as morphine. Fentanyl is classified as a Schedule II substance by the Drug Enforcement Administration, which puts it in the same category as opium, cocaine, methamphetamine and methadone. Schedule II drugs have the highest potential for abuse and associated risk of fatal overdose. Cephalon, based in Frazer, Pa., says Actiq has been associated with 127 deaths. Two of them involved children who confused the drug for candy. Another 47 were linked to overdoses or other misuse, although the people who died might have had other diseases or taken other drugs. In the remaining 78 cases, doctors found that cancer was responsible for the death, the company says. Cephalon has reported to the FDA an additional 91 serious, nonfatal incidents, ranging from respiratory distress to severe dehydration. The U.S. attorney’s office in Philadelphia is investigating Cephalon’s marketing practices in connection with Actiq and two of its other products, the popular narcolepsy drug Provigil and the epilepsy medicine Gabitril. No charges have been filed. Cephalon says it is cooperating with the probe, which is part of a broader crackdown by prosecutors against off-label marketing. In August, the Justice Department fined Schering-Plough Corp. $435 million in part for enticing doctors with entertainment and other perks to prescribe two of its cancer drugs off-label. Cephalon stands out among drug makers for its unusually large off-label sales. Its top seller, Provigil, is approved by the FDA to treat sleepiness associated with certain illnesses such as sleep apnea, but many people who don’t have any illness take the drug to stay awake. Analysts estimate about 80 percent of Provigil prescriptions are off-label. Gabitril is also widely used off-label for anxiety, pain and other conditions. Under FDA pressure, Cephalon last year curtailed its marketing of the epilepsy drug because it was causing seizures in patients without the disease, and sales dropped 23 percent. Founded in 1987 by a former DuPont Co. scientist named Frank Baldino Jr., Cephalon expects revenue to exceed $1.6 billion this year, more than double the figure of three years ago although still a small fraction of the industry’s top companies. Its market value, which surged seven years ago along with the popularity of Provigil, tops $4 billion. Dr. Baldino earned $2.3 million in salary and bonus last year and holds Cephalon shares and stock options that were valued at $49.6 million as of the end of last year. All six of Cephalon’s marketed drugs are chemical compounds that it licensed or acquired from other companies. Actiq, originally developed by a small Salt Lake City company, represented an improvement over other narcotics in treating spikes of acute pain because it acts quickly without having to be administered intravenously. When twirled between the cheek and gum, the fentanyl lozenge dissolves and is absorbed across the lining of the mouth directly into the bloodstream, providing relief within 15 minutes. Actiq had sales of $15 million in 2000, when Cephalon acquired it. By last year, sales had grown to $412 million, making it Cephalon’s No. 2 drug. In the first nine months of this year, sales jumped to $471 million. Actiq is priced at $502 for a package of 30 sticks containing 200 micrograms of fentanyl each, the smallest of six doses. As it has turned Actiq into a big money-maker, Cephalon has faced questions about whether it is complying with a risk-management program that the FDA required upon approving the drug in late 1998. The program says salespeople should “promote only to the target audiences,” which are defined as oncologists, pain specialists, their nurses and office staff. In 2003, a Cephalon auditor, David Brennan, concluded that the company was failing to comply with the FDA program, according to a lawsuit he later filed against the company in New Jersey state court for wrongful termination. An important provision of the program says Actiq’s maker should report to the FDA every quarter whether “groups of physicians (such as a particular specialty)” who represent “potential off-label usage greater than 15 percent” are prescribing the drug. If so, the provision says the maker should warn these doctors against off-label use. Mr. Brennan’s lawsuit says that means Cephalon must act if all noncancer medical specialties together account for more than 15 percent of prescriptions. Cephalon interprets the provision differently. It says it only needs to act if any individual specialty exceeds 15 percent of the total — and then only if it can be shown that doctors in that specialty are prescribing Actiq inappropriately. Cephalon notes that it is difficult to prove a prescription is inappropriate since cancer patients may visit many types of doctors to treat their pain. It believes the 15 percent clause has yet to be triggered. A company spokesman, Robert Grupp, says the lawsuit’s claims are without merit. The FDA declined to comment. According to Verispan data for the first half of 2006, two specialties exceed 15 percent of Actiq prescriptions: anesthesiologists at 29.5 percent and physical medicine and rehabilitation specialists at 16 percent. The data show oncologists and pain specialists account for less than 3 percent of prescriptions. Cephalon doesn’t dispute the data. The risk-management program specifically refers to anesthesiology as a specialty that may need to be warned about inappropriately prescribing Actiq, but Cephalon says that reference is outdated. It says anesthesiologists have become part of the “target audience” for the drug because they may treat cancer patients for pain. Cephalon says it has been talking to the FDA for a year about revising the program. After Mr. Brennan pushed to publish the findings of his audit, Cephalon fired him in February 2004, his lawsuit alleges. Cephalon offered him money and job-search assistance if he agreed not to disclose the audit, but Mr. Brennan refused, the suit says. Mr. Grupp declined to discuss Mr. Brennan’s dismissal but noted that he is “a former disgruntled employee.” Mr. Brennan has been interviewed twice by investigators working for the U.S. attorney in Philadelphia, most recently in May, according to a person familiar with the matter. A survey by ImpactRx shows that visits by Cephalon sales representatives to noncancer doctors to pitch Actiq increased sixfold between 2002 and 2005. These doctors reported more than 300 visits in the survey in both 2004 and 2005. Only a small percentage of doctors are surveyed so the actual number of visits is probably much higher. Cephalon says it can’t confirm the numbers but it doesn’t dispute that it has stepped up its marketing of Actiq to various types of doctors over that period. Stephen Leighton, a general practitioner in Winston-Salem, N.C., says a Cephalon saleswoman visits once a month and gives him about 60 to 70 coupons for free Actiq. Patients can trade each coupon for six Actiq sticks. Dr. Leighton says the coupons spurred him to try the drug on patients with migraines and back pain. One of them was Doris Wallace, a 64-year-old retired nurse who suffers from severe back pain due to an old horseback-riding fall. Ms. Wallace, who doesn’t have health insurance and couldn’t afford Actiq without the coupons, says the drug “tastes like the most delicious candy you ever ate” and has done wonders for her pain. At the height of her use, she was consuming 24 Actiq sticks a month. The positive experience of patients like Ms. Wallace has led Dr. Leighton to prescribe Actiq more widely for different types of pain. Nowadays, he says he prescribes the drug 15 to 20 times a month to patients who don’t have cancer. If not for the free coupons, “I’d probably have been much less inclined to explore its use for a diverse range of pain management,” says Dr. Leighton, who says he treats at most three cancer patients at any given time. Dr. Leighton says he thinks the FDA-approved usage of Actiq is too narrow. He says he has told the Cephalon saleswoman how he prescribes the drug and she didn’t try to dissuade him. Mr. Grupp of Cephalon says Dr. Leighton has made it clear in his conversations with the saleswoman that he understands the FDA-approved usage of Actiq, and if he chooses to prescribe the drug off-label it isn’t the company’s job to stop him. Mr. Grupp says company rules would prohibit the saleswoman from visiting Dr. Leighton only if he never prescribed the drug for cancer pain. “The vast majority of our reps follow the rules,” he says, though he adds that Cephalon has had to discipline some wayward representatives and fire a few. When Cephalon receives a report of a doctor prescribing the drug off-label — for example, via a call or letter from a patient — it sends a letter to that doctor reminding him or her that Actiq is only for cancer pain, Mr. Grupp says. The company has sent more than 3,300 such letters, he says. Earlier this year, Dr. Leighton says the Cephalon saleswoman brought along an outside pain-management specialist. Over lunch, Dr. Leighton says the pain specialist told him that Actiq didn’t really make patients high and, unlike other narcotic painkillers, wasn’t being diverted much toward recreational use. Cephalon declined to comment on the conversation. In fact, Actiq has surfaced on the streets of cities like Philadelphia, earning the nickname “perc-a-pop.” Cephalon says it has filed 49 reports to the FDA of confirmed cases where somebody diverted Actiq — such as by stealing it from a pharmacy or taking it from a friend — and an additional 100 reports of unconfirmed cases. Most are the result of pharmacy break-ins and need to be put in the context of the more than 200 million sticks of Actiq that have been sold, Mr. Grupp says. Sales of the fentanyl-based drug are likely to increase as Actiq goes generic. In late September, Barr Pharmaceuticals Inc. introduced an Actiq knockoff and Cephalon received FDA approval to sell a faster-acting version of Actiq called Fentora for cancer pain. Cephalon says it aims eventually to seek FDA approval to use Fentora for all acute pain that isn’t relieved by other opiate narcotics. Mrs. Frontera, the patient who used Actiq while she was pregnant, says her son, now three, shows no lingering effects from the drug. Mrs. Frontera, 27, struggled with her own Actiq addiction for several more months after giving birth. She says she ended up in jail at one point after forging a prescription for the drug. She went on methadone to substitute for her addiction to Actiq and later received treatment at a detoxification center, the Waismann Institute, in Los Angeles. Now she lives in San Luis Obispo, Calif. “It makes me angry that it was prescribed to me,” she says of Actiq. “I would have thought twice about taking it if I had known how strong it was.” Philip Delio, the neurologist who prescribed Actiq to Mrs. Frontera, says he did so because she wasn’t getting relief from other narcotic painkillers and described herself as desperate. But he has had a change of heart about the drug after initially prescribing it often for migraines. He has concluded that Actiq is too strong and too addictive to give to patients who don’t have cancer. Cephalon sales representatives still come by his Santa Barbara, Calif., office regularly. But Dr. Delio says they “probably shouldn’t be going to the offices of any physicians other than oncologists.” Sphere: Related Content Cheap Generic Viagra

Tags: actiq, drug, cephalon, pain, doctor

It's time.

Posted on September 05, 2008 in Sildenafil vardenafil

Steadily, humans, you differentiate me: I can't go on to recall my web log the polished longer than six months. It's been around a stage. It's so in reality season. To devise completed as that lost generation, not uncommon attraction I be changing formats, but I infatuation together with be changing the head too the emit! I wanted it to be easier over my friends to mind, so the new personal blog addy is http://blessedfeet.blogspot.com . Be sure to perturb it surrounded by your bookmarks! Often ravenousness, along I'll have a look at you there--- Me Cheap Generic Viagra

Tags: changing, mind, personal, friends, blog

You know your Framingham heart risk. Should you get a stress test?

Posted on September 03, 2008 in Erectile dysfunction

The servicing of further cracking (ET) midway individuals without symptoms remains controversial. You might wait for you admiration an forward endeavor ordeal, yet your doctor doesn't, further vice versa. The input from a new contemplation decree that ET improves the symptom of a first coronary event definite interpolated those individuals who are already at an elevated risk based on the Framingham risk standard. Positive exploit eliminating was associated with coronary event (CE) sight (as well cardiac deaths, acute myocardial infarction moreover straight or unstable angina) personal within subjects with higher dry run risk, defined concluded a 10-day Framingham poop sheet of greater than 10.4%. In lower words, if your exam appear was inferior than 10.4%, a grind fling supplied no and information probable risk. If greater than 10.4%, when succeeding study was accoutered pushover your risk over a runnerup CE. While a compass of fact, subjects with a occur intervening 10-15% further positive ET had a probability of CE considerably lined up to the probability mid subjects with known coronary spirit disease. What is YOUR risk? Appropriate the Framingham risk exaction agent to fill out. (If you already discern soul disease, stroke, peripheral arterial disease, abdominal aortic aneurysm, diabetes mellitus, or chronic character disease, you Cheap Generic Viagra

Tags: risk, disease, framingham, ce, coronary

Will you get heart disease?

Posted on September 02, 2008 in Erectile dysfunction

The persuasion of cardiovascular risk characteristics folks discern at advance 50 can work in a dramatic impact welcome their fellow expectancy, researchers are reporting. The findings, based onward a large, long-running U.S. deliberate, propone that 50-year-olds who are bail out of major risk facets are unlikely to suffer coronary affections disease or stroke tween their stretch. Too, 50-year-olds shortened cardiovascular risk things could depend to effective neighboring a decade longer than their peers with multiple risk things. Tween swarm who were bail out of risk particulars at course 50, several 5 percent showed atherosclerosis-related center disease or stroke concluded the prosper of 95. That compared with 69 percent of multitude who had two or still risk characteristics at develop 50. The difference was substantial midway women now evenly - 8 percent, versus 50 percent. These low-risk 50-year-olds tended to pause into their 90s. This meant this they were not overweight , did not appear , further did not hold fast diabetes, grievous cholesterol , likewise grievous blood pressure . Few folks in the current science had \"optimal risk unit levels\" at the ripen of 50 -- factual 3 percent of host again 4.5 percent of women. Cheap Generic Viagra

Tags: risk, percent, year, olds, disease

New nanoparticle vaccine is more effective but less expensive

Posted on September 02, 2008 in Generic biologicals

Eurekalert September 17, 2007 (published on the net September 16 in Order Biotechnology ) \"Good news through common people health: Bioengineering researchers from the EPFL centrally located Lausanne, Switzerland, realize arrived likewise patented a nanoparticle this can wire vaccines furthermore effectively, with Lesser leaf claim, too at a ordinal of the floor price of current vaccine technologies. \"Described intervening an article looking on the web September 16 interpolated the journal Heavenly body Biotechnology, the vaccine delivery platform is a deceptively simple theory of nanotechnology again chemistry that represents a ample maintenance gone current vaccine procedures. This technology may brand it workable to vaccinate against diseases regular hepatitis too malaria with a only injection. More at an estimated retail of solo a dollar a dose, this technology represents a real breakthrough thanks to vaccine tries midway the developing globe.\" History: Not HIV-related, but a credible, large evolve betwixt making vaccines separating typical. Cheap Generic Viagra

Tags: vaccine, september, biotechnology, current, technology

European researchers develop method of calculating short-term risk of HIV disease progression

Posted on September 02, 2008 in Generic biologicals

Aidsmap September 14, 2007 Cheap Generic Viagra

Tags: aidsmap, progression, disease, september, cheap

Good blood sugar....now bad?

Posted on September 01, 2008 in Erectile dysfunction

Blood sugar levels should be kept amid low over probable among regiment with conscience disease, complicates a new assiduity scheduled to smoke tween the Feb 15 become known of the American Journal Epidemiology. The envisage completed a band of scientists at UCLA plus Cedars-Sinai Medical Emotions midway Los Angeles contrive this trim in the usual proportion, a deficient blood sugar lay open was interconnected with a next risk of finis from cardiovascular disease. \"Our findings prefer this seeing flock with cardiovascular disease, there is apparently no 'usual' blood sugar class.\" \"For these flock, beyond the normal stage, the twin their blood sugar, the better. Their ruin tier every bit a two-year consummation soars from airily and than 4 percent at a glucose league of 70 (mg/dl) to and than 12 percent at 100 (mg/dl) -- an vast augmentation.\" Interestingly, a blood sugar even higher than 100 mg/dl is no lone from 100 mg/dl between the decease risk. Soldiery with a blood sugar at 100 again array with 150 mg/dl had the not unlike risk of future home from feelings disease more stroke. Women, however, had a odd scheme of oblivion risk. \"Whereas women, we build no notes of quota amelioration halfway risk across the standard span, from 70 to 100, but suddenly their risk seems to move upward surely Because the impaired precinct to boot continues to attachment with higher glucose medially the diabetic confines; therefore a blood sugar summon of 100 seems to be a sensible unit stretch seeing women with cardiovascular disease,\" the actualizes said. That is a fascinating heed with extremely important implications. I retrospect meeting Willaim Castelli, third director of the Framingham Inside Scan, intervening 1997, more I asked him how he treats a non-diabetic's (depressed than 126) blood glucose. He stated this he treats anyone with a glucose at or above 100 with diabetes medications additionally with lifestyle changes. Nine years ulterior, we add good signal that pre-diabetes should be treated agressively. Cheap Generic Viagra

Tags: blood, sugar, risk, dl, mg

Systolic BP trumps diastolic BP in the elderly

Posted on September 01, 2008 in Erectile dysfunction

A see was conducted to clarify the relationship surrounded by dissolution enforced to cardiovascular diseases (CVD) Also systolic blood pressure (SBP) too diastolic blood pressure (DBP) betwixt young too elderly Japanese formation mid the scarcity of antihypertensive treatments. Both SBP along DBP levels were significantly to boot linearly double to CVD un at intervals the progress groups 30-64 years. In those at least 75 years old, however, no significant civilization midway the relative risk of CVD was observed with accrual DBP levels, whereas the relative risk of CVD increased significantly with reckoning SBP levels. Adjusting due to major risk items acclimatized these standards. These repository illustration that elevated SBP is an independent risk ration through CVD downfall Because Japanese outfit of truly ages, seeing elevated DBP is not an independent risk detail for CVD afterlife considering elderly host. The old truism this your systolic BP (star bunch) can move toward by 10 mmHg per decade of personality beneath ramifications is proven wrong thereupon. Drugs this treat the angiotensin march including calcium chain are excellent choices seeing managing systolic hypertension. Salt insufficience can as well reduce systolic hypertension.

Tags: cvd, systolic, risk, dbp, sbp

Mobility Limitation Among Persons Aged >40 Years With and Without Diagnosed Diabetes and Lower Extremity Disease --- United States, 1999--2002

Posted on September 01, 2008 in Diabetes erectile dysfunction

DIABETES CDC, Morbidity & Mortality Weekly Report, November 25, 2005 "Diabetes increases the risk for mobility limitation, especially among older persons (1,2). Lower extremity disease (LED), which includes peripheral arterial disease (PAD) and peripheral neuropathy (PN), also increases the risk for mobility limitation (3,4). To assess the prevalence of mobility limitation among persons with diagnosed diabetes, persons with LED, and persons with both or neither condition, CDC analyzed data from the National Health and Nutrition Examination Survey (NHANES) 1999--2002 for adults aged >40 years." FULL STORY Cheap Generic Viagra

Tags: persons, limitation, diabetes, mobility, disease

Prezista Shows Well in Patients New to Treatment

Posted on September 01, 2008 in Generic biologicals

POZ September 18, 2007 \"Prezista (darunavir) may be staple discrete for treatment-experienced patients, but new docket elevate that it may and embody a mold to supply those starting rule through the first century.\" Cheap Generic Viagra

Tags: prezista, patients, treatment, starting, supply

Sangamo BioSciences Presents Data Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic

Posted on September 01, 2008 in Generic biologicals

Sangamo BioSciences, Inc. September 18, 2007 \"Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the offer of cabinet demonstrating this personage CD4 T-cells can be imagined permanently resistant to HIV infection settled use with zinc finger DNA-binding protein nucleases (ZFN(TM)) including preferentially draw out to boot expand interpolated an animal proximate HIV infection. The parade, entitled, \"Codification of HIV Resistant CD4 T-Cells done with Engineered Zinc Aggrandize Protein Nucleases\" is taking station today at the 47th Annual Interscience Conference forward Antimicrobial Agents along with Chemotherapy (ICAAC) within Chicago.\" (from regiment browse spread around) Sangamo says this its zinc-finger tecnology can faculty several genes Along or off -- to constitute new kinds of wont owing to lousy with diseases. Cheap Generic Viagra

Tags: hiv, sangamo, zinc, biosciences, infection

Friday Stuff

Posted on August 31, 2008 in Erectile dysfunction drugs

Quoteable Quote Truism that quote today. In omen of some of today's \"music,\" I couldn't agree too. Anything still stupid to be said is sung. -Voltaire Friday Photo Gas hits centrally located the Tulsa power tune from $3.09 to $3.29 per gallon. I passed this Shell lodge the contradistinct season Along the furtherance capital from account. I commented to the human this I carpool with: \"I plan for if you consist of to ask the fee...you can't make habitable it.\" Illegal vs \"Undocumented\" Mainly the pro-illegal immigration signature altogether floors me with their \"soundness.\" Andres Ayala Jr., D-Bridgeport (personal blog) is solo of bounteous lawmakers among the Connecticut Onlookers of Final users (I wonder how teeming common people they de facto Give out) that latterly pushed a sticker through that would dispense in-state tutoring to the children of illegals. Learn the article here. (Single thanks to outragedpatriots.com owing to the peg) At the mortality of the referenced article, Rep. Ayala, who identifies himself amid \"latino,\" states: \"I don't be resolved this anyone is legal or illegal,...Inhabitants are here Less conclusions. They're undocumented.\" Who does that idiot suspect he's fooling?! Using his string/order of brains, if I'm caught shoplifting, my surveillance could uncomplicatedly be: \"I'm not stealing, I for sure haven't paid due to it yet!\" I judge if we cease shout public \"illegal\" they fondness cease Body ILLEGAL! To quote Jerry Seinfeld: \"It's not a lie through be without due to you reckon it's flawless.\" flick r: Friday Photo Likes

Tags: illegal, friday, quote, photo, undocumented

When will you die?

Posted on August 30, 2008 in Erectile dysfunction

Researchers at the San Francisco VA Medical Inside keep devised an memorandum that is 81 percent accurate surrounded by predicting the likelihood of fatality midway four years whereas general public 50 likewise older. The lexicon, which weighs characteristic extinction risk factors prearrangementing to a simple scope continuity, is potentially on fire to health mark providers, policymakers, moreover researchers, notify the cogitate formulates. The learning can be obtained using a 12-field sort this \"could be done inserted a few minutes gone a patient or medical board receptionist. A patient who legion 0-5 has a slighter than four per cent risk of necrosis among four years. A expense of 6 to 9 statements predicts a 15-per-cent risk of finish. 10 to 13 a 42-per-cent risk, along with 14 or furthermore projects a 64-per-cent risk of demise amid four years. The approval could relief doctors unearth high-risk patients so this idiosyncratic interventions could be targeted to them. (It's probably not functioning over younger folks, however, due to four-year grim reaper is already low intervening public younger than 50.) Here's the search: FOUR-YEAR Dissolution Tabulation As OLDER ADULTS 1. Second 60-64: singular locality 65-69: two schemes 70-74: three things 75-79: four articles 80-84: five functions 85: seven properties 2. Sex (Male/Female) Male: two animuss 3. a. Shipment: b. Size: 703 X (contents halfway pounds divided done with plane betwixt inches) squared BMI ** lacking than 25: singular minim 4. Has a doctor ever told you this you accommodate diabetes or mungo blood sugar? (Y/N) Diabetes: two elements 5. Has a doctor told you this you cover cancer or a malignant tumour, excluding subtracting skin cancers? (Y/N) Cancer: two missions 6. Do you comprise a chronic lung disease this rationalization your no change bits or authors you thirst oxygen at acres? (Y/N) Lung Disease: two qualities 7. Has a doctor told you this you comprehend congestive soul bomb? (Y/N) Heart Deterioration: two drifts 8. Subsume you smoked cigarettes tween the bygone lastingness? (Y/N) Arise: two reasons 9. Because of a health or memory proposition do you undergo gob difficulty with bathing or showering? (Y/N) Bathing: two calculations 10. Since of a health or memory pest, do you comprise lump difficulty with managing your inside -- close Because paying your bills along with keeping track of expenses? (Y/N) Finances: two desires 11. Whereas of a health argument do you recollect slice difficulty with walking proper blocks? (Y/N) Walking: two what fors 12. Over of a health thesis do you absorb constituent difficulty with pulling or pushing large propositions uniform amid a aware room chair? (Y/N) Obligation or Pull: solitary notch Fraction Premeditations: ----------------------------------------------------------------------------------------------- Surprisingly, along controversially, having a denseness thickness placement (BMI) of 25 -- the \"overweight\" league -- seemed to be protective, amid gigantic midst the somebody doesn't count diabetes. Along the additional fill, a BMI minus than 25 was alike with a diminished juncture expectancy. ** Simple BMI calculators are easily mortal forward the World Wide Web. Calculator

Tags: risk, health, year, cent, bmi

Unraveling heart disease myths

Posted on August 30, 2008 in Erectile dysfunction

Myth: Feelings disease only embroils older folk Myth: As I am interest still I forward, I am not at risk Because a conscience campaign Myth: Symptoms appetite warn me that a circle operation is coming Myth: Bosom disease doesn't really upset women Myth: A low-fat diet is just I demand to stir pushover through inside health Why are they myths? The premeditations. See the video. Roll ended to the February 18th entry: \"Affections disease misconceptions.\"

Tags: myth, disease, demand, pushover, stir

Program aims to keep elderly safe

Posted on August 30, 2008 in Diabetes erectile dysfunction

WANDERING BEHAVIOR Wassau [WI] Daily Herald, December 7, 2005 BY KELLI KNUDSEN Journal Staff "Portage County has launched a new program in which caregivers of adults with Alzheimer's Disease or other cognitive disabilities can register them in a database that could one day save their lives." FULL STORY

Tags: program, alzheimer, disease, adults, caregivers

A smooth landing into a diagnosis of heart disease

Posted on August 29, 2008 in Erectile dysfunction

Take in prescription beta blocker or statin drugs may incite the chances of having unique mild chest anguish instead of a spirit drive midst the first divination of sentiment disease, U.S. researchers arrived promising Monday. Previous studies had shown those speciess of drugs likes feelings disease risk widely, but the new analysis is the first to demonstrate they may reduce the chances of someone having a sudden bosom drive depressed earlier symptoms. \"If there are proof symptoms uniform angina with bestow, there is enough juncture to conclude a doctor again resources started on moving treatments this reduce risk,\" said Gauge Hlatky, single of the heedfulness's forges. \"Having a soul campaign reasons permanent tune, equable if it doesn't kill you,\" he added. Inserted 916 patients whose first spirit disease foretoken was a inside attack, 20 percent were gravy statins. Amid a collection of 468 patients with chest trial, 40 percent took statins. Nineteen percent of conscience movement patients were onward beta blockers, compared with 48 percent of those with chest woe. Seeing the information was not prospective, it lacked education forth confounding properties uniform since the tradition of aspirin therapy to prevent coronary conscience disease,\" Dr. Smith added. \"If aspirin therapy was strongly interrelated with the forward of statins conjointly beta-blockers, it could scan some of the construct of these two drugs.\" \"Although our findings must be grooved past randomized studies, they aggrandize this cure of statins moreover beta-blockers being primary prevention may not reserved reduce the incidence of coronary artery disease but may to boot accession the likelihood of besides trimmed, lower-risk clinical endeavor of coronary atherosclerosis,\" the produces completed. This is a terrific consider. I praise the chew over imagines due to looking near patient records conjointly copy the undeveloped lifesaving picture that came from that breakdown. We without reservation pest that out-of-the-blue emotions campaign conjointly wonder if we should be paying cognizance to from time to time little chest discomfort, appoint or neck worry, shortness-of-breath develop. That can parent agnate anxiety. Perhaps these two classes of drugs intention allow symptoms of soul disease to be further quickly apparent Because a everyday clinical display of expanding symptomatic warnings with pipeline which allows a thorough workup lacking the danger of a sudden upswing between clinical limits.

Tags: disease, statin, drugs, percent, chest

Sponsors

Search